Advertisement
U.S. markets open in 2 hours 17 minutes
  • S&P Futures

    5,306.25
    -2.00 (-0.04%)
     
  • Dow Futures

    40,136.00
    -8.00 (-0.02%)
     
  • Nasdaq Futures

    18,496.25
    -7.50 (-0.04%)
     
  • Russell 2000 Futures

    2,136.70
    -1.70 (-0.08%)
     
  • Crude Oil

    82.29
    +0.94 (+1.16%)
     
  • Gold

    2,231.00
    +18.30 (+0.83%)
     
  • Silver

    24.76
    +0.01 (+0.03%)
     
  • EUR/USD

    1.0794
    -0.0035 (-0.32%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Vix

    12.99
    +0.21 (+1.64%)
     
  • GBP/USD

    1.2620
    -0.0018 (-0.14%)
     
  • USD/JPY

    151.3560
    +0.1100 (+0.07%)
     
  • Bitcoin USD

    70,898.72
    +748.97 (+1.07%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.45
    +20.47 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

CLASS ACTION UPDATE for CORT, NIO and S: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / May 2, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided.

Corcept Therapeutics Incorporated (CORT)

Class Period: August 2, 2017 - February 5, 2019
Lead Plaintiff Deadline : May 13, 2019
Join the action: https://www.zlk.com/pslra-1/corcept-therapeutics-incorporated-loss-form?prid=1372&wire=1

About the lawsuit: Corcept Therapeutics Incorporated allegedly made materially false and/or misleading statements during the class period and/or failed to disclose that: (1) the Company had improperly paid doctors to promote its drug Korlym; (2) the Company aggressively promoted Korlym for off-label uses; (3) the Company's sole specialty pharmacy was a related party; (4) the Company artificially inflated its revenue and sales using illicit sales practices through a related party; (5) such practices are reasonably likely to lead to regulatory scrutiny; and (6) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To learn more about the Corcept Therapeutics Incorporated class action contact jlevi@levikorsinsky.com.

NIO Inc. (NIO)

Class Period: Purchasers of American Depositary Shares between September 12, 2018 and March 5, 2019
Lead Plaintiff Deadline : May 13, 2019
Join the action: https://www.zlk.com/pslra-1/nio-inc-loss-form?prid=1372&wire=1

About the lawsuit: During the class period, NIO Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) NIO would not be building its own manufacturing plant and would instead continue to rely on JAC Auto to manufacture its vehicles; (2) reductions in government subsidies for electric cars would materially impact NIO’s sales; and (3) as a result, Defendants' statements about NIO's business, operations, and prospects were materially false and misleading at all relevant times.

To learn more about the NIO Inc. class action contact jlevi@levikorsinsky.com.

Sprint Corporation (NYSE:S)

Class Period: January 31, 2019 - April 16, 2019
Lead Plaintiff Deadline : June 21, 2019
Join the action: https://www.zlk.com/pslra-1/sprint-corporation-loss-form?prid=1372&wire=1

The complaint alleges that Sprint made materially false and misleading statements and/or failed to disclose material information. In particular, the complaint alleges that throughout the class period Sprint misrepresented the number of net postpaid subscriber additions in its Form 10-Q for the period ending December 31, 2018. Sprint would later admit that the data was ''incomplete,'' and ''not a substitute for a realistic analysis of the key factors that are most probative of Sprint's overall competitive position and prospects,'' because ''postpaid net additions recently have been driven by ‘free lines’ offered to Sprint customers and the inclusion of less valuable tablet and other non-phone devices, as well as pre to post migrations that do not represent ‘new' Sprint customers.''

To learn more about the Sprint Corporation class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/544018/CLASS-ACTION-UPDATE-for-CORT-NIO-and-S-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders

Advertisement